These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6089052)

  • 1. Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects.
    Löscher W; Vetter M
    Neurosci Lett; 1984 Jun; 47(3):325-31. PubMed ID: 6089052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.
    Löscher W; Vetter M
    Biochem Pharmacol; 1985 May; 34(10):1747-56. PubMed ID: 3924047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved method for isolating synaptosomes from 11 regions of one rat brain: electron microscopic and biochemical characterization and use in the study of drug effects on nerve terminal gamma-aminobutyric acid in vivo.
    Löscher W; Böhme G; Müller F; Pagliusi S
    J Neurochem; 1985 Sep; 45(3):879-89. PubMed ID: 3928810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat.
    Löscher W; Vetter M; Böhme G; Stoltenburg-Didinger G
    J Neural Transm; 1985; 63(2):157-67. PubMed ID: 3930660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a synaptosomal model to determine drug-induced in vivo changes in GABA-levels of nerve endings in 11 brain regions of the rat.
    Löscher W; Vetter M; Müller F; Böhme G; Stoltenburg-Didinger G
    Neurochem Int; 1984; 6(4):441-51. PubMed ID: 20488067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gamma-aminobutyrate content of nerve endings (synaptosomes) in mice after the intramuscular injection of gamma-aminobutyrate-elevating agents: a possible role in anticonvulsant activity.
    Wood JD; Russell MP; Kurylo E
    J Neurochem; 1980 Jul; 35(1):125-30. PubMed ID: 7452248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid.
    Geddes JW; Wood JD
    J Neurochem; 1984 Jan; 42(1):16-24. PubMed ID: 6139419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of synaptosomal GABA levels and their use in determining the in vivo effects of drugs: convulsant agents.
    Wood JD; Russell MP; Kurylo E; Newstead JD
    J Neurochem; 1979 Jul; 33(1):61-8. PubMed ID: 458472
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between drug-induced increases of GABA levels in discrete brain areas and different pharmacological effects in rats.
    Löscher W; Vetter M
    Biochem Pharmacol; 1984 Jun; 33(12):1907-14. PubMed ID: 6428417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drugs on rat brain, cerebrospinal fluid and blood GABA content.
    Ferkany JW; Butler IJ; Enna SJ
    J Neurochem; 1979 Jul; 33(1):29-33. PubMed ID: 379280
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical effects in man and rat of three drugs which can increase brain GABA content.
    Perry TL; Hansen S
    J Neurochem; 1978 Apr; 30(4):679-84. PubMed ID: 148494
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminooxyacetic acid induced accumulation of GABA in the rat brain. Interaction with GABA receptors and distribution in compartments.
    Pagliusi SR; Gomes C; Leite JR; Trolin G
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):210-5. PubMed ID: 6306485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between gamma-aminobutyric acid metabolism and antivitamin B6-induced convulsions.
    Abe M
    J Nutr Sci Vitaminol (Tokyo); 1978; 24(4):419-27. PubMed ID: 712435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of gamma-aminobutyric acid from isolated brain synaptosomes during semicarbazide-induced convulsions.
    Hoshino M; Asakura T; Matsuda M
    J Nutr Sci Vitaminol (Tokyo); 1979; 25(5):367-74. PubMed ID: 541748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.
    Löscher W; Hönack D; Taylor CP
    Neurosci Lett; 1991 Jul; 128(2):150-4. PubMed ID: 1945036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drug-induced increase of brain GABA levels on penicillin focus.
    Elazar Z; Gottesfeld Z
    Experientia; 1975 Jun; 31(6):676-8. PubMed ID: 1095391
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):131-4. PubMed ID: 7300916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.